Aker Biomarine Antarctic AS   Report issue

For profit
Founded: Oslo Norway (2002)
Status: No NME R&D (2002)

Organization Overview

First Clinical Trial
2011
NCT01415388
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Aker Biomarine Antarctic AS

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 7
  • # of Trial APIs: 7